• SENSEX 73,123.83
    -125.56 (--0.17%)
  • BANKNIFTY 54,287.35
    -638.35 (--1.16%)
  • SBI
    950.75 900.80(%)
  • Tonbo Imaging
    1,209.85 1,209.85(%)
  • Cyient
    1,268.00 1,268.00(%)
  • NSE
    1,640.25 1,640.25(%)
  • Bonfiglioli Tran
    527.40 527.40(%)
  • IndusInd Bank
    831.35 750.45(%)
  • Eternal
    317.50 344.75(%)
  • JSW Energy
    440.25 428.00(%)
  • Voltas
    940.00 940.00(%)
  • Swiggy
    174.90 174.90(%)
  • Persistent Systems
    5,688.80 4,242.65(%)
  • Cupid
    302.45 45.40(%)
  • TCS
    2,624.75 3,336.70(%)
  • Infosys
    1,198.30 1,727.85(%)
  • Havells India
    1,003.65 1,003.65(%)
  • PC Jeweller
    17.08 7.45(%)
  • Bharat Forge
    1,680.45 1,265.00(%)
  • C P C L
    1,529.95 1,677.00(%)
  • Netweb Technol.
    4,238.00 2,942.45(%)
  • Lenskart Solut.
    615.80 355.70(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Kwality Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 68403.0
  • ISIN : INE552U01010
3,528.40 -90 (-2.48%)
  • As on 25 Oct 2026 (EOD)
  • Today’s Low

    3,433.10
  • Today’s High

    3,605.00
  • Open

    3,571.00
  • Perv Close

    3,618.30
  • 52W Low

    1,561.00
  • 52W High

    3,949.00

Key Indicators

  • P/E(TTM)

    44.89

  • Mar.Cap (₹Cr.)

    3,661.14

  • Div & Yield %

    0.00

  • Book Value(₹)

    320.51

  • Debt-Equity Ratio

    -2.48

  • AGM Date

    23-Oct-2026

  • EPS

    78.68

  • P/E Ratio

    44.89

Financials Ratios

  • Debt-Equity Ratio

    0.45

  • Mar.Cap (₹Cr.)

    3,661.14

  • RONW (%)

    13.66

  • ROCE (%)

    15.86

Score Board

  • Equity (₹ in Cr.)

    10.38

  • BV (₹)

    320.50

  • Sales( ₹ in Cr.)

    503.06

  • NP (in Cr.)

    67.43

  • NP Var(%)

    69.0

  • Div%

    0.0

  • CPS (₹)

    84.10

  • EPS (₹)

    65.00

  • Traded Value (₹ in Lakhs)

    3,664.56

  • 52 Week High

    3,949.00

  • 52 Week Low

    1,561.00

  • Price BSE

    3532.0

  • Price NSE

    3,528.00

  • Market Capital( in Cr.)

    3,664.56

  • P/C Ratio

    42.00

  • P/E Ratio

    54.30

  • Price Vs.BV

    65.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 503.06 370.20 307.17 250.99 456.13 261.50
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 503.06 370.20 307.17 250.99 456.13 261.50
Other Income 2.86 1.92 1.83 2.94 3.51 1.59
Stock Adjustments -0.28 -1.17 1.48 3.20 2.51 -0.09
Total Income 505.64 370.95 310.48 257.13 462.15 263.00
EXPENDITURE :            
Raw Materials 258.16 181.31 154.66 113.27 203.11 165.50
Power and Fuel Cost 26.69 23.37 17.22 12.96 11.06 6.11
Employee Cost 51.10 41.24 30.43 28.10 18.74 14.48
Other Manufacturing Expenses 2.96 3.32 6.75 4.98 4.57 3.78
Selling and Administration Expenses 44.42 37.31 30.74 32.57 48.71 41.12
Miscellaneous Expenses 2.05 2.03 9.32 17.97 0.72 1.16
Employee Benefit Expenses 51.10 41.24 30.43 28.10 18.74 14.48
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 385.39 288.58 249.12 209.85 286.91 232.14
Operating Profit 120.26 82.37 61.37 47.29 175.24 30.86
Interest 10.97 9.88 10.39 6.61 2.92 2.62
Gross Profit 109.29 72.49 50.98 40.68 172.32 28.24
Depreciation 19.79 18.26 19.51 14.92 10.64 6.44
Profit Before Tax 89.50 54.23 31.47 25.76 161.68 21.80
Current Tax 23.03 15.93 7.92 6.16 41.35 6.22
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.89 -1.59 -0.44 0.14 0.27 0.16
Reported Net Profit 67.35 39.89 23.98 19.47 120.05 15.42
Extraordinary Items -0.09 0.04 -5.31 -12.24 0.00 -0.01
Adjusted Net Profit 67.44 39.85 29.29 31.71 120.05 15.43
Adjustment below Net Profit 0.18 0.01 -0.06 0.00 0.08 0.00
P & L Balance brought forward 246.20 206.30 182.38 162.91 42.78 27.37
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 313.73 246.20 206.30 182.38 162.91 42.78
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 64.90 38.44 23.11 18.76 115.69 14.86
Earnings Per Share(Adj)-Unit Curr 64.90 38.44 23.11 18.76 115.69 14.86
Book Value 320.51 255.43 216.98 193.93 175.17 59.47
Book Value(Adj)-Unit Curr 320.51 255.43 216.98 193.93 175.17 59.47

Shareholding Pattern

  • Promoter Group

    54.86%

  • Public Share Holding

    45.14%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 1,580,677 15.23 1,580,677 6
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,112,211 39.63 4,112,211 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,692,888 54.86 5,692,888 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 259,163 2.50 259,163 7
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 187 0.00 187 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 110,773 1.07 110,773 7
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 370,123 3.57 370,123 16
2] Non Institution
Bodies Corporate 133,887 1.29 133,887 119
Clearing Members 1,639 0.02 1,639 6
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 768,199 7.40 768,199 434
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 65,496 0.63 65,496 381
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,609,366 15.51 1,567,970 12
Individuals holding nominal share capital up to Rs. 1 lakh 1,633,860 15.75 1,633,860 16,899
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 100,540 0.97 100,540 1
Sub Total 4,313,187 41.57 4,271,791 17,856
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 10,376,198 100.00 10,334,802 17,880

Company Background

Kwality Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Kwality Pharmaceuticals Ltd
  • BSE Code : 68403.0
  • ISIN : INE552U01010
  • Incorporation Year

    1983

  • Registered Office

    Village Nagkalan
    Majitha Road, Amritsar,
    Punjab-143601

  • Telephone

    91-183-2774321-25

  • FAX

    91-183-2774477

  • Chairman

  • Managing Director

    Ramesh Kumar

  • Company Secretary

    Gurpreet Kaur

  • Auditor

    Vijay Mehra & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    E-2/3 Ansa Indl Est,
    Saki Vihar Road ,Sakinaka Andheri(E)
    Mumbai - Mumbai - 400072

Kwality Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Kwality Pharma 3,531.70 505.92 503.06 45.22 23.69
Abbott India 25,004.30 7,217.19 6,929.05 32.91 43.78
Astrazeneca Phar 5,988.15 2,304.07 2,275.58 88.26 27.86
Glaxosmi. Pharma 2,404.80 3,932.76 3,790.20 38.42 58.17
Novartis India 1,834.75 393.10 354.33 46.33 15.94
Cipla 1,337.00 20,102.60 18,979.95 35.14 13.88
Bliss GVS Pharma 628.50 773.53 729.81 58.41 12.51
Amrutanjan Healt 487.65 520.13 502.55 26.12 24.16
Fermenta Biotec. 454.90 474.15 450.25 21.24 18.77
Guj. Themis Bio. 327.25 168.25 165.82 87.50 18.05
Ambalal Sarabhai 34.60 19.52 3.94 64.07 6.77